Muutke küpsiste eelistusi

E-raamat: Psychogeriatrics: A Clinical Guide

Edited by , Edited by
  • Formaat: PDF+DRM
  • Sari: Practical Issues in Geriatrics
  • Ilmumisaeg: 31-Aug-2024
  • Kirjastus: Springer International Publishing AG
  • Keel: eng
  • ISBN-13: 9783031584886
  • Formaat - PDF+DRM
  • Hind: 111,14 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: PDF+DRM
  • Sari: Practical Issues in Geriatrics
  • Ilmumisaeg: 31-Aug-2024
  • Kirjastus: Springer International Publishing AG
  • Keel: eng
  • ISBN-13: 9783031584886

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

The book offers a must-have tool primarily for psychiatrists, geriatricians, neurologists, and psychologists, but will also be of interest to general practitioners for first line assessment.





The aim of this book is to establish a gold standard: a reference work to be used as a clinical guide to the assessment of mental illness in older persons in the field. Psychogeriatrics is generally a very specific field in the midst of different disciplines, where there is hardly a clinical consensus on how to best assess and treat elderly subjects with mental or behavioral symptoms, possibly resulting from psychiatric disorders. This book provides clear and practical indications, prepared by a panel of international experts in the field with extensive scientific and clinical experience. Boxes with first and second line actions for assessing and treating mental illness in the elderly are included, and all chapters are uniformly divided into sections on epidemiology, etiopathogenesis, differential diagnosis, assessment, and treatment.
1) Anxiety and depressive disorders in older people.- 2) Bipolar disorder in older people.- 3) Alcohol abuse and addiction in older people.- 4) Treatment of the behavioral and psychological symptoms of dementia.- 5) General considerations on psychopharmacology in older people.- 6) Loneliness and psychiatric disorders in older people.
Nicola Veronese is a certified trained geriatrician, currently working as a community-based geriatrician in ULSS 3 Serenissima, Venice, Italy. His research is mainly epidemiological and focused on the most common diseases affecting older people. In particular, his interest areas are osteoarticular, metabolic (including obesity and diabetes) and cardiovascular diseases, as well as nutrition. He is the author of more than 350 articles published in national and international scientific journals, and of numerous abstracts accepted by national and international congresses.





 





Anna Marseglia is a certified trained psychologist, currently an Assistant Professor at the Division of Clinical Geriatrics; Department of Neurobiology, Care Sciences and Society at Karolinska Institute, Stockholm, Sweden. Her research interests focus on identifying risk and protective factors for Vascular Cognitive Disorders (VCD), the underlying pathological and resilience mechanisms, and determinants of sex differences in VCD. She is a member of the Executive Committee of the International Society of Vascular Behavioural and Cognitive Disorders Society. Since 2019, she co-led a work package withing the EU Joint ProgrammeNeurodegenerative Disease Research (JPND)s SHARED consortium